SinoReg

Organon Pharma (UK) Limited — China drug registrations and re-registration deadlines

10 certificates in the NMPA overseas-manufactured drug database (境外生产药品库), snapshot 2026-09-10. Earliest re-registration deadline: 2029-05-03.

Approval numberProductCertificate expiresRe-registration deadline (Art. 82)
国药准字HJ20160290Proscar
非那雄胺片
2029-11-032029-05-03
国药准字HJ20160291Proscar
非那雄胺片
2029-11-032029-05-03
国药准字HJ20160325Propecia
非那雄胺片
2029-11-062029-05-06
国药准字HJ20160326Propecia
非那雄胺片
2029-11-062029-05-06
国药准字HJ20171081Losartan Potassium Tablets
氯沙坦钾片
2031-08-312031-02-28
国药准字HJ20171082Losartan Potassium Tablets
氯沙坦钾片
2031-08-312031-02-28
国药准字HJ20171083Losartan Potassium Tablets
氯沙坦钾片
2031-08-312031-02-28
国药准字HJ20171245Cozaar
氯沙坦钾片
2031-08-312031-02-28
国药准字HJ20171246Cozaar
氯沙坦钾片
2031-08-312031-02-28
国药准字HJ20202003Cozaar
氯沙坦钾片
2031-08-312031-02-28

Under the Provisions for Drug Registration (药品注册管理办法) Art. 82, an application to renew an overseas-manufactured drug registration is filed with the Center for Drug Evaluation no later than 6 months before the certificate expires; the filing line column is that arithmetic applied to the expiry cell. Art. 84(1): a certificate with no application by expiry is not re-registered and is cancelled at expiry. Every figure is taken from the public NMPA database as of 2026-09-10, or computed from it. Registration data changes; the NMPA portal governs. This page states no view on whether any of these products' Domestic Responsible Person (境内责任人) arrangements meet NMPA Announcement No. 137 — that cannot be determined from a public entry.

All holders  ·  China re-registration deadline index